BEATW
Heartbeam Inc. WarrantKey Statistics
About Heartbeam Inc. Warrant
Heartbeam Inc. Warrant (BEATW) represents an innovative investment opportunity associated with Heartbeam Inc., a cutting-edge healthcare technology company focused on transforming cardiac diagnostics through the integration of artificial intelligence and digital health solutions. By enhancing the accuracy of myocardial infarction diagnoses, Heartbeam's platform facilitates timely interventions that significantly improve patient outcomes. With the increasing demand for remote monitoring and telehealth services in the cardiovascular sector, Heartbeam is well-positioned to capitalize on market growth, making BEATW an attractive consideration for institutional investors seeking exposure to advanced medical technologies with substantial potential for impact.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -164.20% |
| Return on Assets | -90.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.30 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $5.19M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently contracting